Cargando…
Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
Magnetic resonance imaging (MRI)-targeted prostate biopsy is the recommended investigation in men with suspicious lesion(s) on MRI. The role of concurrent systematic in addition to targeted biopsies is currently unclear. Using our prospectively maintained database, we identified men with at least on...
Autores principales: | Leow, Jeffrey J, Koh, Soon Hock, Chow, Marcus WL, Loke, Wayren, Salada II, Rolando, Hong, Seok Kwan, Yeow, Yuyi, Lee, Chau Hung, Tan, Cher Heng, Tan, Teck Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933957/ https://www.ncbi.nlm.nih.gov/pubmed/35488666 http://dx.doi.org/10.4103/aja2021128 |
Ejemplares similares
-
TREXIT: initial experience with transperineal prostate biopsy under local anesthesia in an outpatient setting in South East Asia
por: Yuwono, Arianto, et al.
Publicado: (2021) -
Omitting the systematic prostate biopsy: ready for prime time?
por: Leong, Joon Yau, et al.
Publicado: (2023) -
Cost-effectiveness of MRI targeted biopsy strategies for diagnosing prostate cancer in Singapore
por: Cheng, Li-Jen, et al.
Publicado: (2021) -
Omitting duodenal biopsy in children with suspected celiac disease and extra-intestinal symptoms
por: Bozzola, Mauro, et al.
Publicado: (2017) -
Omitting Sentinel Lymph Node Biopsy in Elderly Patients: A Lost Opportunity?
por: Tuttle, Todd M., et al.
Publicado: (2021)